Pre-Operative MDCT Staging Predicts Mesopancreatic Fat Infiltration-A Novel Marker for Neoadjuvant Treatment?

Sami-Alexander Safi1, Lena Haeberle2, Sophie Heuveldop3

  • 1Department of General, Visceral, Thoracic and Pediatric Surgery (A), Medical Faculty, Heinrich-Heine-University and University Hospital Duesseldorf, Moorenstraße 5, 40225 Düsseldorf, Germany.

Cancers
|September 10, 2021
PubMed

Insights

Preoperative CT scans can detect mesopancreatic fat infiltration in pancreatic cancer patients, predicting incomplete resections and poorer survival. This finding supports considering neoadjuvant therapy for better surgical outcomes.

Area of Science:

  • Surgical Oncology
  • Radiology
  • Gastroenterology

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) has high rates of incomplete surgical resection (R1).
  • Mesopancreatic (MP) fat infiltration is a potential reason for high R1 rates.
  • The utility of pre-operative multi-detector computed tomography (MDCT) in predicting MP fat infiltration requires elucidation.

Purpose of the Study:

  • To evaluate the accuracy of MDCT in detecting mesopancreatic fat infiltration.
  • To correlate MDCT findings with histopathological evidence of tumor infiltration.
  • To assess the impact of MP fat infiltration on surgical resection and patient survival.

Main Methods:

  • Analysis of 242 pancreatic head PDAC patients who underwent mesopancreatic excision (MPE).
  • Radiographic re-evaluation of MDCT scans for mesopancreatic fat stranding (MPS) and vessel involvement.
  • Histopathological analysis of resected MP and perivascular tissues, correlated with radiographic findings.

Main Results:

  • MDCT accurately predicted MP fat infiltration, present in over 78% of patients.
  • Mesopancreatic fat stranding and higher CT-predicted tumor diameter correlated with increased R1 resection rates.
  • Positive MP infiltration was significantly associated with worse overall survival (p=0.023).

Conclusions:

  • Preoperative MDCT assessment of mesopancreatic fat infiltration is valuable for surgical planning.
  • Identifying MP infiltration can guide decisions regarding neoadjuvant therapy to improve R0 resection rates.
  • Mesopancreatic fat stranding should be a key factor in determining neoadjuvant treatment for PDAC.

Related Concept Videos